title: Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidism.
abstract: Altered GH responses to several pharmacological stimuli, including GHRH, have been found in hyperthyroidism. The mechanisms underlying these disturbances have not been fully elucidated. GH-releasing peptide-6 (GHRP-6) is a synthetic hexapeptide that specifically stimulates GH release both in vitro and in vivo. The mechanism of action of GHRP-6 is unknown, but it probably acts by inhibiting the effects of somatostatin on GH release. The aim of this study was to evaluate the effects of GHRP-6 on GH secretion in patients with hyperthyroidism (n = 9) and in control subjects (n = 9). Each subject received GHRP-6 (1 microg/kg, iv), GHRH (100 microg, iv), and GHRP-6 plus GHRH on 3 separate days. GH peak values (mean +/- SE; micrograms per L) were significantly lower in hyperthyroid patients compared to those in control subjects after GHRH alone (9.0 +/- 1.3 vs. 27.0 +/- 5.2) and GHRP-6 plus GHRH (22.5 +/- 3.5 vs. 83.7 +/- 15.2); a lack of the normal synergistic effect of the association of both peptides was observed in thyrotoxicosis. However, a similar GH response was seen in both groups after isolated GHRP-6 injection (31.9 +/- 5.7 vs. 23.2 +/- 3.9). In summary, we have shown that hyperthyroid patients have a normal GH response to GHRP-6 together with a blunted GH responsiveness to GHRH. Our data suggest that thyroid hormones modulate GH release induced by these two peptides in a differential way.
authors.affiliation: Division of Endocrinology, Universidale Federal de São Paulo, Brazil.
authors.forename: J C
authors.initials: JC
authors.lastname: Ramos-Dias
authors.forename: F
authors.initials: F
authors.lastname: Pimentel-Filho
authors.forename: A F
authors.initials: AF
authors.lastname: Reis
authors.forename: A M
authors.initials: AM
authors.lastname: Lengyel
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D004347:Drug Interactions; D005260:Female; D006111:Graves Disease / Q000097:blood / Q000503:physiopathology*; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D007700:Kinetics; D009842:Oligopeptides / Q000008:administration & dosage; D012016:Reference Values; D013997:Time Factors
chemical_list: D009842:Oligopeptides; C041048:growth hormone releasing hexapeptide; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone